IDEXX Laboratories
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $954,288 | $975,543 | $1,003,578 | $964,095 |
Gross Profit | 570,660 | 596,038 | 620,880 | 593,070 |
EBITDA | 261,686 | 341,999 | 300,727 | 334,551 |
EBIT | 307,866 | 268,534 | 304,647 | |
Net Income | 216,149 | 232,841 | 203,298 | 235,579 |
Net Change In Cash | 954,288 | 975,543 | 1,003,578 | 964,095 |
Free Cash Flow | 191,990 | 215,007 | 168,312 | |
Cash | 288,266 | 308,636 | 401,590 | 397,433 |
Basic Shares | 83,056 | 83,056 | 83,393 | 83,957 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $3,897,504 | $3,660,953 | $3,367,324 | $3,215,360 |
Gross Profit | 2,378,927 | 2,189,970 | 2,004,338 | 1,889,432 |
EBITDA | 1,128,337 | 1,097,128 | 1,010,665 | 1,036,624 |
EBIT | 1,097,128 | 898,765 | 932,028 | |
Net Income | 887,867 | 845,042 | 679,089 | 744,845 |
Net Change In Cash | 3,897,504 | 3,660,953 | 3,367,324 | 3,215,360 |
Cost of Revenue | -23,302 | -234,835 | ||
Free Cash Flow | 808,079 | 772,879 | 394,146 | 635,997 |
Cash | 453,932 | 112,546 | 144,454 | |
Basic Shares | 83,056 | 83,978 | 84,600 | 86,572 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | $2.62 |
2024-09-30 | $2.80 |
2024-06-30 | $3.02 |
2024-03-31 | $2.81 |
